First American Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.25M | Buy |
60,244
+44,246
| +277% | +$5.11M | 0.49% | 60 |
|
|
2025
Q4 | $1.68M | Sell |
15,998
-2,145
| -12% | -$201K | 0.12% | 130 |
|
|
2025
Q3 | $1.52M | Buy |
18,143
+12,478
| +220% | +$1.03M | 0.11% | 128 |
|
|
2025
Q2 | $448K | Sell |
5,665
-486
| -8% | -$38.6K | 0.04% | 174 |
|
|
2025
Q1 | $552K | Buy |
6,151
+7
| +0.1% | +$654 | 0.05% | 151 |
|
|
2024
Q4 | $611K | Sell |
6,144
-1,544
| -20% | -$159K | 0.06% | 142 |
|
|
2024
Q3 | $873K | Buy |
7,688
+1,544
| +25% | +$183K | 0.09% | 125 |
|
|
2024
Q2 | $761K | Buy |
6,144
+255
| +4% | +$32.8K | 0.08% | 126 |
|
|
2024
Q1 | $777K | Buy |
5,889
+2,342
| +66% | +$289K | 0.08% | 129 |
|
|
2023
Q4 | $387K | Buy |
3,547
+817
| +30% | +$84.8K | 0.05% | 136 |
|
|
2023
Q3 | $281K | Buy |
+2,730
| New | +$294K | 0.04% | 134 |
|
|
2022
Q3 | – | Sell |
-3,649
| Closed | -$333K | – | 156 |
|
|
2022
Q2 | $333K | Sell |
3,649
-408
| -10% | -$36.2K | 0.05% | 130 |
|
|
2022
Q1 | $333K | Buy |
4,057
+149
| +4% | +$11.7K | 0.05% | 131 |
|
|
2021
Q4 | $300K | Buy |
3,908
+1,010
| +35% | +$80.4K | 0.04% | 136 |
|
|
2021
Q3 | $218K | Sell |
2,898
-100
| -3% | -$7.61K | 0.03% | 149 |
|
|
2021
Q2 | $233K | Sell |
2,998
-202
| -6% | -$15K | 0.04% | 139 |
|
|
2021
Q1 | $235K | Buy |
+3,200
| New | +$236K | 0.04% | 140 |
|
|
2020
Q3 | – | Sell |
-4,625
| Closed | -$341K | – | 144 |
|
|
2020
Q2 | $341K | Buy |
+4,625
| New | +$348K | 0.07% | 102 |
|
|
2019
Q3 | – | Sell |
-2,516
| Closed | -$202K | – | 129 |
|
|
2019
Q2 | $202K | Sell |
2,516
-105
| -4% | -$8.04K | 0.04% | 122 |
|
|
2019
Q1 | $208K | Sell |
2,621
-787
| -23% | -$58.9K | 0.05% | 111 |
|
|
2018
Q4 | $248K | Sell |
3,408
-2,009
| -37% | -$142K | 0.06% | 96 |
|
|
2018
Q3 | $367K | Sell |
5,417
-2,012
| -27% | -$128K | 0.08% | 90 |
|
|
2018
Q2 | $430K | Buy |
7,429
+2,422
| +48% | +$137K | 0.1% | 94 |
|
|
2018
Q1 | $260K | Buy |
5,007
+996
| +25% | +$53.8K | 0.06% | 109 |
|
|
2017
Q4 | $215K | Buy |
+4,011
| New | +$222K | 0.05% | 113 |
|
|
2017
Q3 | – | Sell |
-3,948
| Closed | -$242K | – | 117 |
|
|
2017
Q2 | $242K | Buy |
+3,948
| New | +$240K | 0.07% | 98 |
|
|
2014
Q4 | – | Sell |
-3,646
| Closed | -$206K | – | 104 |
|
|
2014
Q3 | $206K | Buy |
+3,646
| New | +$205K | 0.08% | 101 |
|
|
2014
Q1 | – | Sell |
-4,564
| Closed | -$218K | – | 117 |
|
|
2013
Q4 | $218K | Sell |
4,564
-524
| -10% | -$24K | 0.07% | 119 |
|
|
2013
Q3 | $231K | Sell |
5,088
-236
| -4% | -$10.8K | 0.08% | 118 |
|
|
2013
Q2 | $236K | Buy |
+5,324
| New | +$238K | 0.09% | 110 |
|
Other funds holding MRK
VCM
VPM
First American Trust's MRK Position: Q1 2026 in Review
First American Trust increased its Merck (MRK) stake by 277% in Q1 2026, buying an estimated $5.11M and bringing the position to 60,244 shares worth $7.25M. The position accounts for 0.49% of the portfolio, ranked #60.
First American Trust first reported a position in MRK in Q2 2013 and has held it in 30 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- First American Trust held 60,244 shares of Merck worth $7.25M as of Q1 2026.
- First American Trust bought 44,246 Merck shares in Q1 2026, an estimated $5.11M.
- Merck made up 0.49% of First American Trust's portfolio in Q1 2026, its #60 holding.
- First American Trust first reported a position in Merck in Q2 2013 and has held it in 30 quarters since.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.